511 related articles for article (PubMed ID: 14691167)
1. Effects of TGF-beta2 in perfused human eyes.
Gottanka J; Chan D; Eichhorn M; Lütjen-Drecoll E; Ethier CR
Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):153-8. PubMed ID: 14691167
[TBL] [Abstract][Full Text] [Related]
2. Effects of TGF-beta2, BMP-4, and gremlin in the trabecular meshwork: implications for glaucoma.
Wordinger RJ; Fleenor DL; Hellberg PE; Pang IH; Tovar TO; Zode GS; Fuller JA; Clark AF
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1191-200. PubMed ID: 17325163
[TBL] [Abstract][Full Text] [Related]
3. Effects of latrunculin-B on outflow facility and trabecular meshwork structure in human eyes.
Ethier CR; Read AT; Chan DW
Invest Ophthalmol Vis Sci; 2006 May; 47(5):1991-8. PubMed ID: 16639007
[TBL] [Abstract][Full Text] [Related]
4. Suberoylanilide hydroxamic acid (SAHA) inhibits transforming growth factor-beta 2-induced increases in aqueous humor outflow resistance.
Fujimoto T; Inoue-Mochita M; Iraha S; Tanihara H; Inoue T
J Biol Chem; 2021 Sep; 297(3):101070. PubMed ID: 34389355
[TBL] [Abstract][Full Text] [Related]
5. The effect of cytochalasin D on outflow facility and the trabecular meshwork of the human eye in perfusion organ culture.
Johnson DH
Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2790-9. PubMed ID: 9418732
[TBL] [Abstract][Full Text] [Related]
6. Ultrastructural and biochemical evaluation of the porcine anterior chamber perfusion model.
Bachmann B; Birke M; Kook D; Eichhorn M; Lütjen-Drecoll E
Invest Ophthalmol Vis Sci; 2006 May; 47(5):2011-20. PubMed ID: 16639010
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic disruption of Schlemm's canal cells and outflow facility in anterior segments of human eyes.
Bahler CK; Hann CR; Fautsch MP; Johnson DH
Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2246-54. PubMed ID: 15223802
[TBL] [Abstract][Full Text] [Related]
8. Retroperfusion studies of the aqueous outflow system. Part 2: Studies in human eyes.
Ethier CR; Coloma FM; de Kater AW; Allingham RR
Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2466-75. PubMed ID: 7591636
[TBL] [Abstract][Full Text] [Related]
9. Thrombospondin-1 in the trabecular meshwork: localization in normal and glaucomatous eyes, and induction by TGF-beta1 and dexamethasone in vitro.
Flügel-Koch C; Ohlmann A; Fuchshofer R; Welge-Lüssen U; Tamm ER
Exp Eye Res; 2004 Nov; 79(5):649-63. PubMed ID: 15500824
[TBL] [Abstract][Full Text] [Related]
10. Dexamethasone-induced ocular hypertension in perfusion-cultured human eyes.
Clark AF; Wilson K; de Kater AW; Allingham RR; McCartney MD
Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):478-89. PubMed ID: 7843916
[TBL] [Abstract][Full Text] [Related]
11. Adenoviral gene transfer of active human transforming growth factor-{beta}2 elevates intraocular pressure and reduces outflow facility in rodent eyes.
Shepard AR; Millar JC; Pang IH; Jacobson N; Wang WH; Clark AF
Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):2067-76. PubMed ID: 19959644
[TBL] [Abstract][Full Text] [Related]
12. Morphological and hydrodynamic correlates in monkey eyes with laser induced glaucoma.
Zhang Y; Toris CB; Liu Y; Ye W; Gong H
Exp Eye Res; 2009 Nov; 89(5):748-56. PubMed ID: 19591828
[TBL] [Abstract][Full Text] [Related]
13. Blebbistatin, a novel inhibitor of myosin II ATPase activity, increases aqueous humor outflow facility in perfused enucleated porcine eyes.
Zhang M; Rao PV
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4130-8. PubMed ID: 16249490
[TBL] [Abstract][Full Text] [Related]
14. TGFbeta2-induced changes in human trabecular meshwork: implications for intraocular pressure.
Fleenor DL; Shepard AR; Hellberg PE; Jacobson N; Pang IH; Clark AF
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):226-34. PubMed ID: 16384967
[TBL] [Abstract][Full Text] [Related]
15. Effects of Salidroside on Trabecular Meshwork Cell Extracellular Matrix Expression and Mouse Intraocular Pressure.
Fan Y; Guo L; Wei J; Chen J; Sun H; Guo T
Invest Ophthalmol Vis Sci; 2019 May; 60(6):2072-2082. PubMed ID: 31091314
[TBL] [Abstract][Full Text] [Related]
16. Schlemm's canal and primary open angle glaucoma: correlation between Schlemm's canal dimensions and outflow facility.
Allingham RR; de Kater AW; Ethier CR
Exp Eye Res; 1996 Jan; 62(1):101-9. PubMed ID: 8674505
[TBL] [Abstract][Full Text] [Related]
17. Bone morphogenetic protein-7 is an antagonist of transforming growth factor-beta2 in human trabecular meshwork cells.
Fuchshofer R; Yu AH; Welge-Lüssen U; Tamm ER
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):715-26. PubMed ID: 17251470
[TBL] [Abstract][Full Text] [Related]
18. Effects of ethacrynic acid on Schlemm's canal inner wall and outflow facility in human eyes.
Ethier CR; Coloma FM
Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1599-607. PubMed ID: 10359344
[TBL] [Abstract][Full Text] [Related]
19. Human trabecular meshwork cells express BMP antagonist mRNAs and proteins.
Tovar-Vidales T; Fitzgerald AM; Clark AF
Exp Eye Res; 2016 Jun; 147():156-160. PubMed ID: 27167364
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta2 utilizes the canonical Smad-signaling pathway to regulate tissue transglutaminase expression in human trabecular meshwork cells.
Tovar-Vidales T; Clark AF; Wordinger RJ
Exp Eye Res; 2011 Oct; 93(4):442-51. PubMed ID: 21722634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
